NL-1

Catalog No.S0767 Batch:S076701

Print

Technical Data

Formula

C18H25NO3S
Molecular Weight 335.46 CAS No. 188532-26-5
Solubility (25°C)* In vitro DMSO 67 mg/mL (199.72 mM)
Ethanol 8 mg/mL (23.84 mM)
Water Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O
10.0mg/ml Taking the 1 mL working solution as an example, add 50 μL of 200 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description The mitochondrial mitoNEET ligand NL-1 is a mitoNEET inhibitor, which induces a concentration-dependent decrease in cell viability with an IC50 of 47.35 μM and 56.26 μM in REH and REH/Ara-C cells respectively. The docking studies using liver mitochondrial suspensions show the IC50 of NL-1 binding for [3H]-rosiglitazone is 0.9 μM and the Ki for NL-1 site 1 and site 2 was 4.78 and 2.77, respectively.
Targets
mitoNEET [1]
(in [3H]-rosiglitazone binding test)		 mitoNEET [2]
(in REH cells viability test)		 mitoNEET [2]
(in REH/Ara-C cells viability test)
0.9 μM 47.35 μM 56.26 μM
In vitro

NL-1 is a mitoNEET inhibitor with antileukemic effect, which induces a concentration-dependent decrease in cell viability of REH and REH/Ara-C, and impaires the migratory ability of leukemic cells irrespective of the chemoattractant used.[2]
In vivo

NL-1 shows antileukemic activity in an in vivo mouse ALL model.[2]

Protocol (from reference)

Cell Assay:

[2]
  • Cell lines

    REH, REH/Ara-C and ALL (SUP-B15, TOM-1, JM1, NALM-1, NALM-6, BV-173) cell lines

  • Concentrations

    10, 20, 30, 40, 50, 60, 70, 80, 100 μM

  • Incubation Time

    72 h

  • Method

    ALL cell lines are plated at 5×104cells/well in a 96-well plate. Following treatment with NL-1, viable cells are quantitated using a Cell Counting Kit-8.
Animal Study:

[2]
  • Animal Models

    Female NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice (6-8 month old) injected with TOM-1 ALL cells

  • Dosages

    10 mg/kg

  • Administration

    i.p.

Selleck's NL-1 has been cited by 1 publication

Mitochondrial GCN5L1 acts as a novel regulator for iron homeostasis to promote sorafenib sensitivity in hepatocellular carcinoma [ J Transl Med, 2024, 22(1):593] PubMed: 38918793

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.